Progress and prospects in pharmacogenetics of antidepressant drugs (Q30249569)

13 June 2017

1 reference

title

Progress and prospects in pharmacogenetics of antidepressant drugs (English)

1 reference

13 June 2017

Chiara Fabbri

0 references

Alessandro Serretti

0 references

Edoardo Spina

0 references

Concetta Crisafulli

1 reference

13 June 2017

Marco Calabrò

series ordinal

1 reference

13 June 2017

language of work or name

English

0 references

publication date

16 June 2016

1 reference

Expert Opinion on Drug Metabolism & Toxicology

13 June 2017

published in

1 reference

13 June 2017

1 reference

13 June 2017

1 reference

13 June 2017

page(s)

1157-1168

1 reference

Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys

13 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Switching antidepressant class does not improve response or remission in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Looking on the bright side of serotonin transporter gene variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Successful antidepressant chronotherapeutics enhance fronto-limbic neural responses and connectivity in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetics in major depression: a comprehensive meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Metabolic drug interactions with new psychotropic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Clinical applications of CYP genotyping in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetics: from bench to byte--an update of guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Role of human UGT2B10 in N-glucuronidation of tricyclic antidepressants, amitriptyline, imipramine, clomipramine, and trimipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

A UGT2B10 splicing polymorphism common in african populations may greatly increase drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Biological insights from 108 schizophrenia-associated genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

A genomewide association study of citalopram response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

A genome-wide association study of antidepressant response in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Rare copy number variation in treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Copy number variants and therapeutic response to antidepressant medication in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

The role of AUTS2 in neurodevelopment and human evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Preliminary genome-wide association study of bipolar disorder in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Association of a brain methylation site with clinical outcomes in depression does not replicate across populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

A genome-wide association study of a sustained pattern of antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Stress, depression, and neuroplasticity: a convergence of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Increased hippocampal neurogenesis and p21 expression in depression: dependent on antidepressants, sex, age, and antipsychotic exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Modulation of synaptic plasticity in the hippocampus by hippocampus-derived estrogen and androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Gender differences in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Effects of repeated citalopram treatments on chronic mild stress-induced growth associated protein-43 mRNA expression in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Inflammation and clinical response to treatment in depression: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Neuroplastic changes in depression: a role for the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Contribution of common genetic variants to antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Epigenetic regulation of BDNF expression according to antidepressant response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Gene expression biomarkers of response to citalopram treatment in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Clinical application of pharmacogenomics: the example of HLA-based drug-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Pharmacogenetics of mood disorders: what clinicians need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Perspectives on genetic and genomic technologies in an academic medical center: the duke experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

Neuronal cell adhesion genes and antidepressant response in three independent samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425255.2016.1202237

10.1080/17425255.2016.1202237

21 January 2018

Identifiers

DOI

1 reference

13 June 2017

1 reference